top of page
ImunoTera offers a unique biotechnological platform capable of restoring and activating immune system functions
Technology
The platform, called Act-Tera, is based on a recombinant protein designed with high therapeutic precision to combat various types of cancer.
Our platform
The Act-Tera platform is versatile and functions as a therapeutic vaccine, which can be applied through different immunological strategies.
.png)
Mechanisms of action
With 100% Brazilian technology, the therapeutic vaccine increases the body's natural defenses against cancer, through three mechanisms:
1
Blocks
pathways that weaken the Immune System
2
Directs
for the defense cells of the Immune System
3
Active
defense cells that eliminate cancer target cells
Investors and partners
bottom of page